Abstract:Highlights • Systemic sclerosis is a disease that affects patients' functionality of the foot, with a greater impact on the pain scale. • There is a correlation between the final Foot Function Index score and the final Systemic Sclerosis Questionnaire score in patients with systemic sclerosis. • Improving foot functionality could help improving the overall functionality of the sclerosis patient. Background Progressive systemic sclerosis or systemic scleroderma (SS) is a chronic and rare autoimmune disease that mainly affects the skin and various internal organs. Raynaud's phenomenon and digital ulcers are some of the symptoms that affect the foot, causing a decrease in the quality of life of patients. The objective of this study is to determine the functionality of the feet in patients with SS and determine the impact on their daily lives. Methods A sample of 165 patients (154 women, 11 men) diagnosed with SS with a mean age of 46.29 ± 11.36 years and a mean body mass index (BMI) of 24.90 ± 5.77 was recruited. Each participant completed the Foot Function Index (FFI) questionnaire and the Systemic Sclerosis Questionnaire (SySQ). A multivariate analysis was performed to determine which factors were related to a higher score in both questionnaires. Results 32.1% of the participants (n = 53) had claw toe deformities, 79.4% (n = 131) Raynaud's disease and 20% (n = 33) a history of foot ulcers. 51.5% of the participants (n = 85) presented symptoms in their nails, the most frequent sign being thickening, hardening and yellow coloration. The final score of the FFI questionnaire was 3.51 ± 2.41 (0–9.9), the pain subscale being the highest, with a score of 5.06 ± 2.75, followed by foot disability (3.26 ± 2.91) and difficulty performing activities (1.55 ± 2.22). The final score of the SySQ questionnaire was 0.95 ± 0.45 (0.18–2.45), and the subscales with the highest score were symptom frequency (1.30 ± 0.47), symptom intensity (1.11 ± 0.55), and general skill limitation (0.47 ± 0.51). A high correlation was observed between the final FFI score and the final SySQ score (r = 0.712; p=<0.001). Also, between foot activity limitation and general skill limitation (r = 0.658; p=<0.001). A moderate correlation was observed between foot pain score and overall symptom intensity (r = 0.482; p=<0.001). Also, between foot disability and overall symptom frequency (r = 0.556; p=<0.001). The multivariate analysis (R 2 0.51) showed that the final FFI score had a significant relationship with the final SySQ score (p < 0.001). No significant correlation was found between age (p = 0.15), gender (p = 0.49), BMI (p = 0.74) or time of diagnosis (p = 0.57) and FFI. Conclusion SS is a disease that affects foot functionality in patients, with a greater impact on the pain scale. There is a correlation between the final FFI score and the final SySQ score, so improving foot functionality could help to improve the overall functionality of the patient with sclerosis.

Functional capacity, physical activity, and arterial stiffness in patients with systemic sclerosis

Disease specific determinants of cardiopulmonary fitness in systemic sclerosis

Factors associated with physical function among people with systemic sclerosis: a SPIN cohort cross-sectional study

Effects of supervised exercise program and home exercise program in patients with systemic sclerosis: A randomized controlled trial

Assessment of circulating biomarkers and hemodynamic response during stress to detect early cardiopulmonary complications in systemic sclerosis

Cardiovascular Risk in Patients with Ankylosing Spondylitis

Serum levels of vascular dysfunction markers reflect disease severity and stage in systemic sclerosis patients

Investigating physical inactivity and associated health parameters in patients with systemic lupus erythematosus

Assessing the quality of forced vital capacity measurement in patients with systemic sclerosis

Do functionality, strength, vascularization, inflammatory and biopsychosocial status improve by biopsychosocial model-based exercise in SSc?

Pain, fatigue and hand function closely correlated to work ability and employment status in systemic sclerosis

Reduced exercise capacity in patients with systemic sclerosis is associated with lower peak tissue oxygen extraction: a cardiovascular magnetic resonance-augmented cardiopulmonary exercise study

Metabolic fingerprinting of systemic sclerosis: a systematic review

Biomarkers for skin involvement and fibrotic activity in scleroderma

The functional disabilities of the dominant and opposite hands in patients with systemic sclerosis

Further insight into systemic sclerosis from the vasculopathy perspective

Endothelial dysfunction and increased carotid intima-media thickness in patients with spondyloarthritis without traditional cardiovascular risk factors

Accelerated calciprotein crystallization time (T50) is correlated with impaired lung diffusion capacity in systemic sclerosis

Impact of foot functionality in patients with systemic sclerosis: An observational study

Retinal Microvasculature in Systemic Sclerosis Patients and the Correlation between Nailfold Capillaroscopic Findings and Optical Coherence Angiography Results

Prognostic and functional importance of both overt and subclinical left ventricular systolic dysfunction in systemic sclerosis